中国神经精神疾病杂志
中國神經精神疾病雜誌
중국신경정신질병잡지
CHINESE JOURNAL OF NERVOUS AND MENTAL DISEASES
2001年
2期
103-105
,共3页
陈毅昌%陈家强%张良诚%蔡教壁%伍新尧
陳毅昌%陳傢彊%張良誠%蔡教壁%伍新堯
진의창%진가강%장량성%채교벽%오신요
精神分裂症%相关性研究%补体缺陷%6号染色体
精神分裂癥%相關性研究%補體缺陷%6號染色體
정신분렬증%상관성연구%보체결함%6호염색체
目的探讨补体第四成份C4A、C4B基因缺陷与精神分裂症的相关性。方法采用Amp-RFLP(amplification restriction fragment length polymorphism)方法,对192例精神分裂症患者和142例健康对照组样本补体第四成份C4A、C4B基因缺陷的相关性进行研究。结果精神分裂症患者与补体第四成份C4A基因缺陷纯合子C4AQ0/C4AQ0的发病率显著高于对照组(χ2=8.54,P<0.01),关联强度RR值为6.8。精神分裂症患者与补体第四成份C4B基因缺陷纯合子C4BQ0/C4BQ0的发病率与对照组进行比较无显著差异性(χ2=0.11,P>0.05),关联强度RR值为0.73。结论本实验结果提示补体第四成份C4A基因缺陷纯合子与精神分裂症有密切相关性。
目的探討補體第四成份C4A、C4B基因缺陷與精神分裂癥的相關性。方法採用Amp-RFLP(amplification restriction fragment length polymorphism)方法,對192例精神分裂癥患者和142例健康對照組樣本補體第四成份C4A、C4B基因缺陷的相關性進行研究。結果精神分裂癥患者與補體第四成份C4A基因缺陷純閤子C4AQ0/C4AQ0的髮病率顯著高于對照組(χ2=8.54,P<0.01),關聯彊度RR值為6.8。精神分裂癥患者與補體第四成份C4B基因缺陷純閤子C4BQ0/C4BQ0的髮病率與對照組進行比較無顯著差異性(χ2=0.11,P>0.05),關聯彊度RR值為0.73。結論本實驗結果提示補體第四成份C4A基因缺陷純閤子與精神分裂癥有密切相關性。
목적탐토보체제사성빈C4A、C4B기인결함여정신분렬증적상관성。방법채용Amp-RFLP(amplification restriction fragment length polymorphism)방법,대192례정신분렬증환자화142례건강대조조양본보체제사성빈C4A、C4B기인결함적상관성진행연구。결과정신분렬증환자여보체제사성빈C4A기인결함순합자C4AQ0/C4AQ0적발병솔현저고우대조조(χ2=8.54,P<0.01),관련강도RR치위6.8。정신분렬증환자여보체제사성빈C4B기인결함순합자C4BQ0/C4BQ0적발병솔여대조조진행비교무현저차이성(χ2=0.11,P>0.05),관련강도RR치위0.73。결론본실험결과제시보체제사성빈C4A기인결함순합자여정신분렬증유밀절상관성。
Objective To assess the association between the gene of complement C4A, C4B deficiency and schizophrenia. Methods 192 patients with schizophrenia and 142 healthy controls were tested with the amplification restriction fragment length polymorphism (Amp-RFLP) technique.Results The frequency of C4AQ0/C4AQ0 homozygote was higher in the patient group than in the control group (χ2=8.54, P<0.01). The relative risk (RR) of C4AQ0/C4AQ0 homozygote for schizophrenia was 6.8. There was no increased frequency of C4B deficiency in patients with schizophrenia (χ2=0.11, P>0.05, RR=0.73).Conclusions These results indicate that there is a positive association between complement C4A dificiency and schizophrenia. Moreover, our study did not support a widespread association between a deficiency in complement component C4B and schizophrenia.